Intervention

endostar

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLCNCT04063449 · 2019-08-20

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLCNCT03614065 · 2017-02-21

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC PatientsNCT02865304 · 2016-12-01

Common conditions

Angiogenesis1 Breast Cancer1 Non-small Cell Lung Cancer1 Non-squamous Non-small Cell Lung Cancer1

Leading sponsors

Dong Wang1 Fujian Cancer Hospital1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Trial status mix

UNKNOWN3

Phase mix

NA1

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.